Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Acute Myeloid Leukemias
In brief
The purpose of this study is to assess if adding revumenib to standard chemotherapy improves outcomes in participants with AML with certain genetic mutations compared to chemotherapy alone. The study will also assess the safety of adding revumenib to chemotherapy.
Key facts
- Study ID
- NCT07211958
- Run by
- Syndax Pharmaceuticals
- People needed
- 468
- Starts
- 2025-11-25
- Expected to finish
- 2031-01-01
- Last updated by the study team
- 2026-07-23
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Trial Site — Nedlands, Western Australia, Australia (enrolling)
- Clinical Trial Site — Perth, Western Australia, Australia (enrolling)
- Clinical Trial Site — Gosford, Australia (enrolling)
- Clinical Trial Site — Wollongong, Australia (enrolling)
- Clinical Trial Site — Sankt Pölten, Lower Austria, Austria (enrolling)
- Clinical Trial Site — Graz, Styria, Austria (enrolling)
- Clinical Trial Site — Leoben, Styria, Austria (enrolling)
- Clinical Trial Site — Linz, Austria (enrolling)
- Clinical Trial Site — Ghent, Belgium (enrolling)
- Clinical Trial Site — Fortaleza, Paraná, Brazil (enrolling)
- Clinical Trial Site — Barretos, São Paulo, Brazil (enrolling)
- Clinical Trial Site — Jaú, Brazil (enrolling)
- Clinical Trial Site — Porto Alegre, Brazil (enrolling)
- Clinical Trial Site — Montreal, Canada (enrolling)
- Clinical Trial Site — Toronto, Canada (enrolling)
- Clinical Trial Site — Angers, Loire-Atlantique, France (enrolling)
- Clinical Trial Site — Bayonne, France (enrolling)
- Clinical Trial Site — Bordeaux, France (enrolling)
- Clinical Trial Site — Batumi, Adjara, Georgia (enrolling)
- Clinical Trial Site — Tbilisi, Georgia (enrolling)
- Clinical Trial Site 1 — Tbilisi, Georgia (enrolling)
- Clinical Trial Site 2 — Tbilisi, Georgia (enrolling)
- Clinical Trial Site — Tbilisi, Georgia (enrolling)
- Clinical Trial Site — Tübingen, Baden-Wurttemberg, Germany (enrolling)
- Clinical Trial Site — Melbourne, Victoria, Australia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.